Hila Goldberg

Hila Goldberg

Auto-generated profile, based on publicly available information

Hila Goldberg

Faculty of Medical and Health sciences, Tel Aviv University, Israel

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2024 in Canadian Journal of Ophthalmology
Verified
Journal Article
Closed access
BEBita Esmaeli
Bita Esmaeli
JFJanet Fan
Janet Fan
HGHila Goldberg
Hila Goldberg
TLTracy Lu
Tracy Lu
NGNeil D. Gross
Neil D. Gross
RFRenata Ferrarotto
Renata Ferrarotto

21 April 2020 in Eye
Verified
Journal Article
Closed access
PDF file
HGHila Goldberg
Hila Goldberg
APAyelet Priel
Ayelet Priel
OZOfira Zloto
Ofira Zloto
TKTal Koval
Tal Koval
LVLipaz Varkel
Lipaz Varkel
GSGuy J. Ben Simon
Guy J. Ben Simon

17 June 2014 in BMC Neurology
Verified
Journal Article
Open access
PDF file
HGHila Goldberg
Hila Goldberg
AWArie Weinstock
Arie Weinstock
Niels BergslandNiels Bergsland
Niels Bergsland
MDMichael G Dwyer
Michael G Dwyer
OFOsman Farooq
Osman Farooq
RZRobert Zivadinov
Robert Zivadinov
Background: Temporal lobe epilepsy (TLE) and idiopathic generalized epilepsy (IGE) patients have each been associated with extensive brain atrophy findings, yet to date there are no reports of head to head comparison of both patient groups. Our aim was to assess and compare between tissue-specific and structural brain atrophy findings in TLE to IGE patients and to healthy controls (HC). Methods: TLE patients were classified in TLE lesional (L-TLE) or non-lesional (NL-TLE) based on presence or absence of MRI temporal structural abnormalities. High resolution 3 T MRI with automated segmentation by SIENAX and FIRST tools were performed in a group of patients with temporal lobe epilepsy (11 L-TLE and 15 NL-TLE) and in15 IGE as well as in 26 HC. Normal brain volume (NBV), normal grey matter volume (NGMV), normal white matter volume (NWMV), and volumes of subcortical deep grey matter structures were quantified. Using regression analyses, differences between the groups in both volume and left/right asymmetry were evaluated. Additionally, laterality of results was also evaluated to separately quantify ipsilateral and contralateral effects in the TLE group. Results: All epilepsy groups had significantly lower NBV and NWMV compared to HC (p < 0.001). L-TLE had lower hippocampal volume than HC and IGE (p = 0.001), and all epilepsy groups had significantly lower amygdala volume than HC (p < = 0.004). In L-TLE, there was evidence of atrophy in both ipsilateral and contralateral structures. Conclusions: Our study revealed that TLE and IGE patients demonstrated similar overall tissue-specific brain atrophy, although specific structures differences were appreciated. L-TLE also appeared to behave differently than NL-TLE, with atrophy not limited to the ipsilateral side.

27 August 2025 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
BEBita Esmaeli
Bita Esmaeli
ZLZhouxuan Li
Zhouxuan Li
TLTracy J Lu
Tracy J Lu
HGHila Goldberg
Hila Goldberg
JNJing Ning
Jing Ning
RFRenata Ferrarotto
Renata Ferrarotto
Purpose To evaluate the presenting symptoms, and the overall survival (OS) and disease-specific survival (DSS) in patients with lacrimal gland adenoid cystic carcinoma (LGACC). Methods This retrospective single-centre cohort study included all consecutive patients with LGACC treated by the primary author from November 1998 through August 2024. Demographic data, presenting symptoms, the histological subtype of LGACC, type of surgical treatment, adjuvant radiotherapy or chemotherapy, T category at presentation and survival data were reviewed. Correlations between histological subtypes, T-category, type of surgery (eye sparing vs orbital exenteration), and DSS and OS were analysed. Results 52 patients had a median age of 43.5 years (range: 9–71). Pain was the most common symptom but was only present in 17 patients (33%), 26 patients (50%) had orbital exenteration and 25 (48%) had eye-sparing surgery. Eye-sparing surgery was offered to selected patients only since 2007. Overall, 47 patients (90%) had postoperative radiotherapy and 18 patients (35%) developed distant metastasis. At last contact, 14 patients (27%) had died of disease (median follow-up=60 months). The 5-year and 10-year DSS rates for patients who had eye-sparing surgery (87.1% and 76.2%, respectively) were better than for patients who had orbital exenteration (62.3% and 57.5%, respectively, p=0.049). There was a significant difference between the DSS for basaloid (solid) versus non-basaloid histologic subtypes with a worse survival for basaloid histology (p=0.00057). Conclusions Pain was present in only one-third of patients with LGACC. The 5-year and 10-year DSS and OS rates are better than previously reported ‘historic data’.

3 July 2024 in Ophthalmic Plastic & Reconstructive Surgery
Verified
Journal Article
Closed access
HGHila Goldberg
Hila Goldberg
XJXinyang M.S. Jiang
Xinyang M.S. Jiang
JFJanet B.S. Fan
Janet B.S. Fan
JZJiawei Zhao
Jiawei Zhao
JNJing Ning
Jing Ning
BEBita Esmaeli
Bita Esmaeli
Purpose: Lacrimal gland (LG) adenocarcinomas (ACs) are rare, with limited data. We compared clinicopathologic features and local recurrence, distant metastasis, and survival rates between LG AC and LG adenoid cystic carcinoma (ACC). Methods: The records of LG AC patients treated from 2008 to 2022 and LG ACC patients treated from 1998 to 2022 at the same center were retrospectively reviewed. Results: The study included 20 patients with AC; 10 de-novo AC, 10 ex-pleomorphic AC; and 51 ACC patients. The median age at diagnosis was 61 years for de-novo AC, 54 years for ex-pleomorphic AC, and 45 years for ACC. All groups had male predominance. The initial T category was T2 in 50% (5/10) of de-novo ACs; 60% (6/10) of ex-pleomorphic ACs; and 59% (30/51) of ACCs. Perineural invasion was present in 33% (5/15) of ACs and 90% (45/50) of ACCs (p < 0.001). Of the 20 AC patients, 14 had eye-sparing surgery; 4 had orbital exenteration; and 2 had unresectable disease. All AC patients received postoperative radiotherapy and 15 (75%) received concurrent chemotherapy. Fourteen AC patients were tested for human growth factor receptor 2 expression, and 10 (71%) were human growth factor receptor 2 positive; 5 received human growth factor receptor 2-targeted therapy. AC and ACC had similar 5-year recurrence rates (20% and 33%, respectively, p = 0.31) and metastasis rates (20% and 34%, respectively, p = 0.30). de-novo AC, ex-pleomorphic AC, and ACC had similar 5-year disease-specific survival rates (80%, 79%, and 81%, respectively, p > 0.99). Conclusions: LG AC and ACC have similar baseline clinicopathologic features, except that perineural invasion is more common in ACC, and similar recurrence, metastasis, and survival rates. Human growth factor receptor 2-targeted therapy may be appropriate in some patients with LG AC.

21 October 2024 in Eye
Verified
Journal Article
Closed access
PDF file
RARoee Arnon
Roee Arnon
HGHila Goldberg
Hila Goldberg
GBGuy J. Ben-Simon
Guy J. Ben-Simon
APAyelet Priel
Ayelet Priel
OZOfira Zloto
Ofira Zloto
OSOded Sagiv
Oded Sagiv